Aurobindo Pharma Announcements
Intimation of receipt of Notice of Compliance from Health Canada by Curateq Biologics Private Limited, a wholly owned subsidiary of the Company for its biosimilar...
09 Jan, 2026 | 03:19pm • Source: BSE
Intimation of plant visit by investors.
08 Jan, 2026 | 05:16pm • Source: BSE
Submission of certificate under Regulation 74(5) of SEBI (DP Regulations, 2018 for the quarter ended 31.12.2025.
05 Jan, 2026 | 12:20pm • Source: BSE
Intimation of the acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Limited by Auro Pharma Limited, a wholly...
01 Jan, 2026 | 06:05pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about update on acquisition of 26% stake in Swarnaakshu Solar Power Private Limited.
30 Dec, 2025 | 11:54am • Source: NSE
Update on acquisition of 26% Stake in Swarnaakshu Solar Power Private Limited.
30 Dec, 2025 | 11:15am • Source: BSE
This is to inform that Curateq Biologics Private Limited a wholly owned subsidiary of the Company has mutually agreed to terminate its agreement with BioFactura...
27 Dec, 2025 | 11:54am • Source: BSE
Intimation of closure of trading window
24 Dec, 2025 | 11:59am • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about acquisition of additional 20% stake in Luoxin Aurovitas Pharma (Chengdu) Co. Ltd, China, a joint venture company
23 Dec, 2025 | 02:06pm • Source: NSE
Intimation of acquisition of additional 20% stake in Luoxin Aurovitas (Chengudu) Co.Ltd, China, a Joint Venture company.
23 Dec, 2025 | 01:28pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Inspection at Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of the...
18 Dec, 2025 | 10:11am • Source: NSE
Intimation of completion of US FDA inspection at Unit-IV of APL Healthcare Limited Limited, a wholly owned subsidiary of the Company.
18 Dec, 2025 | 10:06am • Source: BSE
Intimation of investor meet.
15 Dec, 2025 | 02:33pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange a copy of Notice published in Newspapers
02 Dec, 2025 | 11:26am • Source: NSE
Submission of notice published in newspapers.
02 Dec, 2025 | 11:13am • Source: BSE
Submission of newspaper publication.
27 Nov, 2025 | 12:09pm • Source: BSE
Intimation of completion of US FDA inspection of Unit II of Eugia Pharma Specialities Limited, Biwadi, a wholly owned subsidiary of the Company.
14 Nov, 2025 | 04:06pm • Source: BSE
Intimation of investors meeting.
14 Nov, 2025 | 11:49am • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about classification of US FDA Inspection at Unit-I of Apitoria Pharma Private Limited as VAI
14 Nov, 2025 | 10:56am • Source: